Results 201 to 210 of about 110,008 (267)

Relevance of residual tricuspid regurgitation for right ventricular reverse remodelling after tricuspid valve intervention in patients with severe tricuspid regurgitation and right‐sided heart failure

European Journal of Heart Failure, EarlyView.
Right ventricular reverse remodelling after transcatheter tricuspid valve intervention (TTVI). Optimal tricuspid regurgitation (TR) reduction is critical for right ventricular reverse remodelling. CMR, cardiac magnetic resonance; echo, echocardiography; RV EDV, right ventricular end‐diastolic volume. Abstract Aims Right ventricular reverse remodelling (
Ludwig T. Weckbach, Lukas Stolz, Philipp M. Doldi, Hannah Glaser, Cecilia Ennin, Michael Kothieringer, Thomas J. Stocker, Michael Näbauer, Mohammad Kassar, Sara Bombace, Karl‐Patrik Kresoja, Philipp Lurz, Fabien Praz, Holger Thiele, Volker Rudolph, Steffen Massberg, Jörg Hausleiter   +16 more
wiley   +1 more source

Mechanistic insights into the diuretic activity of sugarcane leaf extract using untargeted metabolomics and bioinformatics. [PDF]

Front Plant Sci
Pan X, Hao E, Xie J, Tang PL, Wen J, Du Z, Deng J, Hou X.   +7 more
europepmc   +1 more source

Machine learning approach to identify phenotypes in patients with ischaemic heart failure with reduced ejection fraction

European Journal of Heart Failure, EarlyView.
Summary of the machine learning clustering methodology and results of the study. Clusters are identified using machine learning approach in the learning set population evaluating specific combinations of multiple characteristics. Then identified clusters are predicted and tested in the learning set to evaluate their association with outcomes.
Luca Monzo, Emmanuel Bresso, Kenneth Dickstein, Bertram Pitt, John G.F. Cleland, Stefan D. Anker, Carolyn S.P. Lam, Mandeep R. Mehra, Dirk J. van Veldhuisen, Barry Greenberg, Faiez Zannad, Nicolas Girerd   +11 more
wiley   +1 more source

Efficacy of ambulatory intravenous diuresis for chronic heart failure patients: Insights from the DEA-HF trial. [PDF]

ESC Heart Fail
Gruber A, Abbo AR, Volis I, Aronson D, Girerd N, Kristensen SL, Zukermann R, Alberkant N, Sitnitsky E, Kruger A, Khasis P, Bravo E, Elad B, Levin LH, Caspi O.   +14 more
europepmc   +1 more source

The transcriptional profile of iron deficiency in patients with heart failure: Heme‐sparing and reduced immune processes

European Journal of Heart Failure, EarlyView.
The analysis workflow, findings and potential clinical consequences of iron deficiency in heart failure (HF). From 881 patients with worsening HF, whole blood transcriptome was analysed using the Affymetrix Human Transcriptome Array (HTA) 2.0. Subjects were stratified according to their transferrin saturation (TSAT) levels as iron‐deficient (TSAT <20%)
Niels Grote Beverborg, Ridha I.S. Alnuwaysir, George Markousis‐Mavrogenis, Martijn F. Hoes, Haye H. van der Wal, Simon P.R. Romaine, Mintu Nath, Andrea Koekoemoer, John G.F. Cleland, Chim C. Lang, Stefan D. Anker, Kenneth Dickstein, Marco Metra, Leong L. Ng, Dirk J. van Veldhuisen, Adriaan A. Voors, Nilesh J. Samani, Peter van der Meer   +17 more
wiley   +1 more source

Acute and chronic hemodynamic effects of the basic therapeutic regimen for congestive heart failure. diuretics, low salt diet and bed rest.

, 1984
Hirotaka Nishijima, Hisakazu Yasuda, Kazusuke Ito, Rinji Murakami, Kunio HAYASHI, Mitsuru YAMAZAKI, Takeshi Hattori   +6 more
openalex   +2 more sources

Clinical applications of urinary sodium in heart failure from prognostic marker to clinical tool. [PDF]

ESC Heart Fail
Dauw J.
europepmc   +1 more source

Proteins associated with rehospitalization, mortality and diuretic resistance in acutely decompensated heart failure. [PDF]

ESC Heart Fail
Hubbell KT, Rao VS, Scherzer R, Shlipak MG, Ivery-Miranda JB, Bansal N, Cox ZL, Testani JM, Estrella MM.   +8 more
europepmc   +1 more source

Congestive Nephropathy: A Neglected Entity in Heart Failure. [PDF]

Cureus
Avci M, Avci Merdin F, Güven Avci E.
europepmc   +1 more source

Minimization or withdrawal of oral pharmacotherapy in chronic heart failure patients with improved myocardial function: A systematic review

European Journal of Heart Failure, EarlyView.
This systematic review included seven studies that reported the outcomes of minimization or withdrawal of oral pharmacotherapy in chronic heart failure (HF) patients with improved myocardial function. There is a dearth of existing evidence, which supports only loop diuretic withdrawal and possibly carvedilol monotherapy.
Yuxiang Luo, Wenbin Xiao, Yusuf Z. Sener, Wouter C. Meijers, Robert M.A. van der Boon, Elfatih A. Hasabo, Osama Soliman, Rudolf A. de Boer, Kadir Caliskan   +8 more
wiley   +1 more source